Prevpac

Company: TAP Pharmaceuticals
Approval Status: Approved February 1999
Treatment for: Gastroenterology
Areas: Gastrointestinal
Possible similar drugs: Prevpac

| General Information |

General Information

Prevpac (lansoprazole, clarithromycin and amoxicillin), Rx, has been approved for the eradication of H. pylori to reduce the risk of duodenal ulcer recurrence. This efficacy supplement changed the duration of treatment with lansoprazole from 14 to 10 days and included recent minor changes to the clarithromycin labeling.

< back to top

Prevpac Drug Information

The Prevpac drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.